Canntab Therapeutics Ltd (CTABF)
0.0001
0.00 (0.00%)
USD |
OTCM |
Sep 27, 16:00
Canntab Therapeutics EPS Diluted (Quarterly): -0.0074 for Feb. 28, 2023
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| February 28, 2023 | -0.0074 |
| November 30, 2022 | -0.0222 |
| August 31, 2022 | -0.0077 |
| May 31, 2022 | -0.0314 |
| February 28, 2022 | -0.0079 |
| November 30, 2021 | -0.0239 |
| August 31, 2021 | -0.0161 |
| May 31, 2021 | -0.0548 |
| February 28, 2021 | -0.0133 |
| November 30, 2020 | -0.0152 |
| August 31, 2020 | -0.0223 |
| May 31, 2020 | -0.0214 |
| February 29, 2020 | -0.0228 |
| November 30, 2019 | -0.0151 |
| August 31, 2019 | -0.0151 |
| May 31, 2019 | -0.0149 |
| February 28, 2019 | -0.0225 |
| November 30, 2018 | -0.0229 |
| August 31, 2018 | -0.0153 |
| May 31, 2018 | -0.0511 |
| March 31, 2018 | -0.0004 |
| February 28, 2018 | -0.0477 |
| December 31, 2017 | -0.0006 |
| September 30, 2017 | -0.0003 |
| June 30, 2017 | -0.0004 |
| Date | Value |
|---|---|
| March 31, 2017 | -0.0003 |
| December 31, 2016 | -0.201 |
| September 30, 2016 | -0.0007 |
| June 30, 2016 | -0.001 |
| March 31, 2016 | 0.0102 |
| December 31, 2015 | -0.1206 |
| September 30, 2015 | -0.0008 |
| June 30, 2015 | -0.0008 |
| March 31, 2015 | -0.001 |
| December 31, 2014 | -0.0018 |
| September 30, 2014 | -0.0028 |
| June 30, 2014 | -0.0016 |
| March 31, 2014 | -0.0009 |
| December 31, 2013 | 0.0048 |
| September 30, 2013 | -0.0019 |
| June 30, 2013 | -0.0029 |
| March 31, 2013 | -0.0089 |
| December 31, 2012 | -1.580 |
| September 30, 2012 | -0.008 |
| June 30, 2012 | -0.0119 |
| March 31, 2012 | -0.013 |
| December 31, 2011 | -0.0059 |
| September 30, 2011 | -0.0327 |
| June 30, 2011 | -0.0021 |
| March 31, 2011 | -0.0041 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-0.0548
Minimum
May 2021
-0.0074
Maximum
Feb 2023
-0.0201
Average
-0.0187
Median
EPS Diluted (Quarterly) Benchmarks
| Biosyntech Inc | -- |
| Cotinga Pharmaceuticals Inc | -0.0152 |
| Choom Holdings Inc | -0.0079 |
| Acasti Pharma Inc | -0.24 |
| Aurinia Pharmaceuticals Inc | 0.01 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.3058M |
| Revenue (Quarterly) | -0.0164M |
| Total Expenses (Quarterly) | 0.3724M |